Evidence map›Paper›PMID 28892011›Full record

ReviewMaterials (Basel, Switzerland)2017

Review on the Antimicrobial Properties of Carbon Nanostructures.

Ahmed Al-Jumaili, Surjith Alancherry, Kateryna Bazaka, Mohan V Jacob

Abstract readReview
In one paragraph

Review in Materials (Basel, Switzerland), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 101 papers.

0numbers the graph read from it
0cells of the map it votes in
101citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

101 citing papers in PubMed.

  1. Review
  2. Review
  3. Review of Antimicrobial Properties of Carbon Nanomaterials.International journal of molecular sciences · 2026
    Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Review
  19. Review
  20. Article

41 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Ahmed Al-JumailiElectronics Materials Lab, College of Science and Engineering, James Cook University, Townsville, QLD 4811, Australia. Ahmed.Aljumaili@my.jcu.edu.au.
Surjith AlancherryElectronics Materials Lab, College of Science and Engineering, James Cook University, Townsville, QLD 4811, Australia. Surjith.Alancherry@my.jcu.edu.au.
Kateryna BazakaElectronics Materials Lab, College of Science and Engineering, James Cook University, Townsville, QLD 4811, Australia. kateryna.bazaka@qut.edu.au.
Mohan V JacobElectronics Materials Lab, College of Science and Engineering, James Cook University, Townsville, QLD 4811, Australia. Mohan.Jacob@jcu.edu.au.ORCID 0000-0002-2598-7193

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Swift developments in nanotechnology have prominently encouraged innovative discoveries across many fields. Carbon-based nanomaterials have emerged as promising platforms for a broad range of applications due to their unique mechanical, electronic, and biological properties. Carbon nanostructures (CNSs) such as fullerene, carbon nanotubes (CNTs), graphene and diamond-like carbon (DLC) have been demonstrated to have potent broad-spectrum antibacterial activities toward pathogens. In order to ensure the safe and effective integration of these structures as antibacterial agents into biomaterials, the specific mechanisms that govern the antibacterial activity of CNSs need to be understood, yet it is challenging to decouple individual and synergistic contributions of physical, chemical and electrical effects of CNSs on cells. In this article, recent progress in this area is reviewed, with a focus on the interaction between different families of carbon nanostructures and microorganisms to evaluate their bactericidal performance.

Indexed as

antimicrobial propertiescarbon nanostructurescarbon nanotubesdiamond-like carbonfullerenegraphene

Identifiers

PMID28892011
PMCPMC5615720

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.